Non-medical Use, Abuse and Dependence on Prescription Opioids Among U.S. Adults: Psychiatric, Medical and Substance Use Correlates
Overview
Affiliations
Background: Non-medical use of prescription opioids carries risks including development of abuse/dependence. Such use may correlate with psychiatric, medical, and substance use characteristics.
Methods: Cross-sectional survey, the 2002-2004 National Survey on Drug Use and Health. Respondents 18 years and older (n=91,823). Bivariate and multivariable associations were investigated.
Results: The prevalence of past-year non-medical use of prescription opioids was 4.5%. Of those with non-medical use, 12.9% met criteria for abuse/dependence. On multivariable analysis, past-year non-medical use was associated with panic (AOR 1.2; 95% CI 1.04-1.5), depressive (AOR 1.2; 95% CI 1.01-1.5) and social phobic/agoraphobic symptoms (AOR 1.2; 95% CI 1.1-1.4). Among those with past-year non-medical prescription opioid use, those with abuse/dependence were more likely to have panic (AOR 1.7; 95% CI 1.2-2.4) and social phobic/agoraphobic symptoms (AOR 1.7; 95% CI 1.2-2.4). In addition, they were more likely to report fair/poor health (AOR 2.1; 95% CI 1.4-3.0), have misused another class of prescription medication (AOR 1.7; 95% CI 1.2-2.3), have used heroin (AOR 2.9; 95% CI 1.2-6.9) and initiated substance use before the age of 13 (AOR 4.7; 95% CI 1.1-19.9).
Conclusions: Non-medical use of prescription opioids is common. Furthermore, nearly 13% of those with non-medical use meet criteria for abuse/dependence. Panic, social phobia and agoraphobia, low self-rated health status, and other substance misuse among those with non-medical use of prescription opioids should alert clinicians to screen for abuse and dependence.
Hassan M, Shahzadi S, Yasir M, Chun W, Kloczkowski A Genes (Basel). 2024; 15(8).
PMID: 39202362 PMC: 11353898. DOI: 10.3390/genes15081003.
Rhew I, Le V, Ramirez J, Fleming C, Kilmer J, Delawalla M Addict Behav. 2023; 143:107711.
PMID: 37011567 PMC: 10168644. DOI: 10.1016/j.addbeh.2023.107711.
Landry H, Kingsbury M, Hamilton H, Colman I Soc Psychiatry Psychiatr Epidemiol. 2023; 58(10):1483-1492.
PMID: 36932238 DOI: 10.1007/s00127-023-02450-y.
Earnest J, Hatch M, Hurlocker M Subst Use Misuse. 2022; 57(14):2117-2125.
PMID: 36308739 PMC: 10238058. DOI: 10.1080/10826084.2022.2136497.
Psychological distress and the risk of drug overdose death.
Aram J, Spencer M, Garnett M, Hedegaard H J Affect Disord. 2022; 318:16-21.
PMID: 36057284 PMC: 9664726. DOI: 10.1016/j.jad.2022.08.115.